Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanoma-associated antigen A4 (None)
- Target
- None
- Molecular classification
- Cancer/Testis Antigen Family, Protein
01
Overview
Melanoma-associated antigen A4 (MAGE-A4) is a protein encoded by the MAGEA4 gene. It belongs to the cancer/testis antigen (CTA) family and is aberrantly expressed in various tumors while having restricted expression in normal adult tissues. MAGE-A4 regulates cell proliferation, inhibits G1 arrest, and modulates the p53 pathway. Due to its expression profile and immunogenicity, it is an attractive target for cancer immunotherapy, with vaccines and adoptive T-cell therapies being developed.
- Other names
- MAGEA4CT1.4MAGE-41MAGE-X2MAGE4MAGE4AMAGE4B
02
Mechanism of action
Cancer vaccines targeting CD8+ cytotoxic T lymphocytes and CD4+ helper T cells; Genetically modified autologous T cells targeting MAGE-A4
03
Biological functions
Cell proliferationInhibition of G1 arrestModulation of p53 pathwayRegulation of cell cycle
04
Disease associations
Cancer
05
Safety considerations
Potential for off-target effects in normal tissues expressing MAGE-A4 (e.g., testis).Immune-related adverse events associated with immunotherapy.
06
Biomarkers
MAGE-A4 expression levels
Beyond the preview
Go deeper on Melanoma-associated antigen A4 (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Melanoma-associated antigen A4 (None).